T. Nagasawa

Novel therapeutic vaccine: Granulysin and new DNA vaccine against Tuberculosis

Y. Kaneda, P. Saunderson, T. Nakajima, 2011, Human vaccines.

Novel Prophylactic Vaccine Using a Prime-Boost Method and Hemagglutinating Virus of Japan-Envelope against Tuberculosis

Y. Kaneda, T. Nakajima, D. McMurray, 2011, Clinical & developmental immunology.

A Novel Therapeutic and Prophylactic Vaccine (HVJ-Envelope / Hsp65 DNA + IL-12 DNA) against Tuberculosis Using the Cynomolgus Monkey Model

Y. Kaneda, T. Nakajima, S. Yoshida, 2010, Procedia in Vaccinology.

Novel prophylactic and therapeutic vaccine against tuberculosis.

Y. Kaneda, P. Saunderson, T. Nakajima, 2009, Vaccine.

Development of therapeutic and prophylactic vaccine against Tuberculosis using monkey and transgenic mice models

Y. Kaneda, P. Saunderson, T. Nakajima, 2011, Human vaccines.

A Human Myeloid Cell Line Producing Stem Cell Growth Factor, KPB-M15, Secretes Another Growth Factor Active on Murine Hematopoietic Progenitor Cells

A. Hiraoka, T. Nagasawa, S. Shimizu, 1999, Acta Haematologica.

Cloning, expression, and characterization of a cDNA encoding a novel human growth factor for primitive hematopoietic progenitor cells.

A. Hiraoka, T. Nagasawa, M. Hagiya, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Evaluation of a novel vaccine (HVJ-liposome/HSP65 DNA+IL-12 DNA) against tuberculosis using the cynomolgus monkey model of TB.

Y. Kaneda, T. Nakajima, M. Matsumoto, 2007, Vaccine.